Vanguard Group Inc Vaccinex, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.44 - $131.17 $305 - $91,031
694 Added 0.09%
732,859 $469,000
Q3 2022

Nov 14, 2022
BUY
$0.48 - $109.22 $2,352 - $535,178
4,900 Added 0.67%
732,165 $363,000
Q1 2022

May 13, 2022
BUY
$0.92 - $1.94 $95,756 - $201,921
104,083 Added 16.7%
727,265 $960,000
Q3 2021

Nov 12, 2021
BUY
$2.11 - $2.81 $47,597 - $63,387
22,558 Added 3.76%
623,182 $1.35 Million
Q2 2021

Aug 13, 2021
BUY
$2.01 - $3.0 $1.21 Million - $1.8 Million
600,624 New
600,624 $1.68 Million

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $154M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email